Clindamycin vs Tofacitinib

Clindamycin vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Clindamycin and Tofacitinib.

Mechanism of Action

Clindamycin: Binds 50S ribosomal subunit inhibiting protein synthesis.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Clindamycin — 2-3 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Clindamycin — C18H33ClN2O5S; Tofacitinib — C16H20N6O.

Molecular Weight: Clindamycin — 424.9830 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Clindamycin — Small molecule; Tofacitinib — Small molecule.